{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:06:37Z","timestamp":1771002397298,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2005,11,26]],"date-time":"2005-11-26T00:00:00Z","timestamp":1132963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1007\/s00262-005-0099-1","type":"journal-article","created":{"date-parts":[[2005,11,25]],"date-time":"2005-11-25T14:08:26Z","timestamp":1132927706000},"page":"1100-1110","source":"Crossref","is-referenced-by-count":13,"title":["Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy"],"prefix":"10.1007","volume":"55","author":[{"given":"Evgeny","family":"Arons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Sorbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryalice","family":"Stetler-Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth M.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Liewehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Pastan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Kreitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,26]]},"reference":[{"key":"99_CR1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00062752-200307000-00002","volume":"10","author":"GR Goodman","year":"2003","unstructured":"Goodman GR, Bethel KJ, Saven A (2003) Hairy cell leukemia: an update. Curr Opin Hematol 10:258\u2013266","journal-title":"Curr Opin Hematol"},{"key":"99_CR2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1468-0734.2002.00304.x","volume":"6","author":"A Polliack","year":"2002","unstructured":"Polliack A (2002) Hairy cell leukemia: biology, clinical diagnosis, unusual manifestations and associated disorders discussion (449\u2013350). Rev Clin Exp Hematol 6:366\u2013388","journal-title":"Rev Clin Exp Hematol"},{"key":"99_CR3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.V82.4.1277.1277","volume":"82","author":"BA Robbins","year":"1993","unstructured":"Robbins BA, Ellison DJ, Spinosa JC, Carey CA, Lukes RJ, Poppema S, Saven A, Piro LD (1993) Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 82:1277\u20131287","journal-title":"Blood"},{"issue":"Suppl 1","key":"99_CR4","first-page":"57","volume":"14","author":"E Matutes","year":"1994","unstructured":"Matutes E, Morilla R, Owusu-Ankomah K, Houliham A, Meeus P, Catovsky D (1994) The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma 14(Suppl 1):57\u201361","journal-title":"Leuk Lymphoma"},{"key":"99_CR5","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.V79.4.888.bloodjournal794888","volume":"79","author":"G Juliusson","year":"1992","unstructured":"Juliusson G, Liliemark J (1992) Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2\u2019-deoxyadenosine (CdA): relation to opportunistic infections. Blood 79:888\u2013894","journal-title":"Blood"},{"key":"99_CR6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1200\/JCO.1997.15.3.1138","volume":"15","author":"MA Hoffman","year":"1997","unstructured":"Hoffman MA, Janson D, Rose E, Rai KR (1997) Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up. J Clin Oncol 15:1138\u20131142","journal-title":"J Clin Oncol"},{"key":"99_CR7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/10428199709114177","volume":"25","author":"M Blasinska-Morawiec","year":"1997","unstructured":"Blasinska-Morawiec M, Robak T, Krykowski E, Hellmann A, Urbanska-Rys H (1997) Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine\u2013a report of three cases. Leuk Lymphoma 25:381\u2013385","journal-title":"Leuk Lymphoma"},{"key":"99_CR8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.leu.2401999","volume":"15","author":"E Matutes","year":"2001","unstructured":"Matutes E, Wotherspoon A, BritoBabapulle V, Catovsky D (2001) The natural history and clinico-pathological features of the variant form of hairy cell leukemia. Leukemia 15:184\u2013186","journal-title":"Leukemia"},{"key":"99_CR9","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1182\/blood.V96.1.71","volume":"96","author":"IW Flinn","year":"2000","unstructured":"Flinn IW, Kopecky KJ, Foucar MK, Head D, Bennett JM, Huchison R, Corbett W, Cassileth P, Habermann T, Golomb H, Rai K, Eisenhauer E, Appelbaum F, Cheson B, Grever MR (2000) Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood 96:2981\u20132986","journal-title":"Blood"},{"key":"99_CR10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.leu.2402784","volume":"17","author":"F Maloisel","year":"2003","unstructured":"Maloisel F, Benboubker L, Gardembas M, Coiffier B, Divine M, Sebban C, Blanc M, Abgrall JF, Lederlin P, Harousseau JL, Blaise AM, Grosbois B, Morice P, Ghandour C, Castaigne S (2003) Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients. Leukemia 17:45\u201351","journal-title":"Leukemia"},{"key":"99_CR11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1200\/JCO.2003.05.093","volume":"21","author":"GR Goodman","year":"2003","unstructured":"Goodman GR, Burian C, Koziol JA, Saven A (2003) Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 21:891\u2013896","journal-title":"J Clin Oncol"},{"key":"99_CR12","first-page":"155","volume":"36","author":"MS Tallman","year":"1999","unstructured":"Tallman MS, Peterson LC, Hakimian D, Gillis S, Polliack A (1999) Treatment of hairy-cell leukemia: current views. Semin Hematol 36:155\u2013163","journal-title":"Semin Hematol"},{"key":"99_CR13","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1182\/blood.V92.6.1918","volume":"92","author":"A Saven","year":"1998","unstructured":"Saven A, Burian C, Koziol JA, Piro LD (1998) Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 92:1918\u20131926","journal-title":"Blood"},{"key":"99_CR14","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.1998.16.9.3007","volume":"16","author":"BD Cheson","year":"1998","unstructured":"Cheson BD, Sorensen JM, Vena DA, Montello MJ, Barrett JA, Damasio E, Tallman M, Annino L, Connors J, Coiffier B, Lauria F (1998) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients. J Clin Oncol 16:3007\u20133015","journal-title":"J Clin Oncol"},{"key":"99_CR15","first-page":"1153","volume":"8","author":"B Filleul","year":"1994","unstructured":"Filleul B, Delannoy A, Ferrant A, Zenebergh A, Van Daele S, Bosly A, Doyen C, Mineur P, Glorieux P, Driesschaert P, Sokal C, Martiat P, Michaux JL (1994) A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia 8:1153\u20131156","journal-title":"Leukemia"},{"key":"99_CR16","first-page":"2019","volume":"8","author":"A Carbone","year":"1994","unstructured":"Carbone A, Reato G, Di Celle PF, Lauria F, Foa R (1994) Disease eradication in hairy cell leukemia patients treated with 2- chlorodeoxyadenosine [letter]. Leukemia 8:2019\u20132020","journal-title":"Leukemia"},{"key":"99_CR17","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood.V83.10.2906.2906","volume":"83","author":"JF Seymour","year":"1994","unstructured":"Seymour JF, Kurzrock R, Freireich EJ, Estey EH (1994) 2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood 83:2906\u20132911","journal-title":"Blood"},{"key":"99_CR18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.leu.2400513","volume":"11","author":"JF Seymour","year":"1997","unstructured":"Seymour JF, Talpaz M, Kurzrock R (1997) Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7- year follow-up. Leukemia 11:42\u201347","journal-title":"Leukemia"},{"key":"99_CR19","first-page":"1046","volume":"86","author":"F Lauria","year":"2001","unstructured":"Lauria F, Lenoci M, Annino L, Raspadori D, Marotta G, Bocchia M, Forconi F, Gentili S, La Manda M, Marconcini S, Tozzi M, Baldini L, Zinzani PL, Foa R (2001) Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia. Haematologica 86:1046\u20131050","journal-title":"Haematologica"},{"key":"99_CR20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1365-2141.2001.03143.x","volume":"115","author":"H Hagberg","year":"2001","unstructured":"Hagberg H, Lundholm L (2001) Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia. Br J Haematol 115:609\u2013611","journal-title":"Br J Haematol"},{"key":"99_CR21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood-2003-01-0014","volume":"102","author":"J Nieva","year":"2003","unstructured":"Nieva J, Bethel K, Saven A (2003) Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood 102:810\u2013813","journal-title":"Blood"},{"key":"99_CR22","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1182\/blood-2003-02-0630","volume":"102","author":"DA Thomas","year":"2003","unstructured":"Thomas DA, O\u2019Brien S, Bueso-Ramos C, Faderl S, Keating MJ, Giles FJ, Cortes J, Kantarjian HM (2003) Rituximab in relapsed or refractory hairy cell leukemia. Blood 102:3906\u20133911","journal-title":"Blood"},{"key":"99_CR23","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1200\/JCO.2005.11.437","volume":"23","author":"RJ Kreitman","year":"2005","unstructured":"Kreitman RJ, Squires DR, Stetler-Stevenson M, Noel P, Fitzgerald DJ, Wilson WH, Pastan I (2005) Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies. J Clin Oncol 23:6719\u20136729","journal-title":"J Clin Oncol"},{"key":"99_CR24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM200107263450402","volume":"345","author":"RJ Kreitman","year":"2001","unstructured":"Kreitman RJ, Wilson WH, Bergeron K, Raggio M, Stetler-Stevenson M, FitzGerald DJ, Pastan I (2001) Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia. New Engl J Med 345:241\u2013247","journal-title":"New Engl J Med"},{"key":"99_CR25","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V61.6.1132.1132","volume":"61","author":"LP Ruco","year":"1983","unstructured":"Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD (1983) Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 61:1132\u20131137","journal-title":"Blood"},{"key":"99_CR26","first-page":"189","volume":"13","author":"BR Smith","year":"1985","unstructured":"Smith BR, Rosenthal DS, Ault KA (1985) Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity. Exp Hematol 13:189\u2013193","journal-title":"Exp Hematol"},{"key":"99_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ajh.2830290206","volume":"29","author":"R Bassan","year":"1988","unstructured":"Bassan R, Rambaldi A, Allavena P, Abbate M, Marini B, Barbui T (1988) Association of large granular lymphocyte\/natural killer cell proliferative disease and second hematologic malignancy. Am J Hematol 29:85\u201393","journal-title":"Am J Hematol"},{"key":"99_CR28","first-page":"146","volume":"80","author":"P Airo","year":"1995","unstructured":"Airo P, Rossi G, Facchetti F, Marocolo D, Garza L, Lanfranchi A, Prati E, Brugnoni D, Malacarne F, Cattaneo R (1995) Monoclonal expansion of large granular lymphocytes with a CD4+ CD8dim+\/\u2212 phenotype associated with hairy cell leukemia. Haematologica 80:146\u2013149","journal-title":"Haematologica"},{"key":"99_CR29","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1182\/blood.V87.9.3795.bloodjournal8793795","volume":"87","author":"JC Kluin-Nelemans","year":"1996","unstructured":"Kluin-Nelemans JC, Kester MG, Melenhorst JJ, Landegent JE, van de Corput L, Willemze R, Falkenburg JH (1996) Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 87:3795\u20133802","journal-title":"Blood"},{"key":"99_CR30","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1182\/blood.V91.11.4224","volume":"91","author":"HC Kluin-Nelemans","year":"1998","unstructured":"Kluin-Nelemans HC, Kester MG, van deCorput L, Boor PP, Landegent JE, van Dongen JJ, Willemze R, Falkenburg JH (1998) Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemia. Blood 91:4224\u20134231","journal-title":"Blood"},{"key":"99_CR31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.leu.2403149","volume":"18","author":"EH Spaenij-Dekking","year":"2004","unstructured":"Spaenij-Dekking EH, Van der Meijden ED, Falkenburg JH, Kluin-Nelemans JC (2004) Clonally expanded T cells in hairy cell leukemia patients are not leukemia specific. Leukemia 18:176\u2013178","journal-title":"Leukemia"},{"key":"99_CR32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood.V93.1.251","volume":"93","author":"L Corput van de","year":"1999","unstructured":"van de Corput L, Kluin-Nelemans HC, Kester MG, Willemze R, Falkenburg JH (1999) Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones. Blood 93:251\u2013259","journal-title":"Blood"},{"key":"99_CR33","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/sj.leu.2403174","volume":"17","author":"EH Spaenij-Dekking","year":"2003","unstructured":"Spaenij-Dekking EH, Van Delft J, Van Der Meijden E, Hiemstra HS, Falkenburg JH, Koning F, Drijfhout JW, Kluin-Nelemans JC (2003) Synaptojanin 2 is recognized by HLA class II-restricted hairy cell leukemia-specific T cells. Leukemia 17:2467\u20132473","journal-title":"Leukemia"},{"key":"99_CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/10428190009057632","volume":"37","author":"XY Xie","year":"2000","unstructured":"Xie XY, Sorbara L, Kreitman RJ, Fukushima PI, Kingma DW, Stetler-Stevenson M (2000) Development of lymphoproliferative disorder of granular lymphocytes in association with hairy cell leukemia. Leukemia & Lymphoma 37:97\u2013104","journal-title":"Leukemia & Lymphoma"},{"key":"99_CR35","first-page":"173","volume":"1","author":"KP McCarthy","year":"1992","unstructured":"McCarthy KP, Sloane JP, Kabarowski JH, Matutes E, Wiedemann LM (1992) A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol 1:173\u2013179","journal-title":"Diagn Mol Pathol"},{"key":"99_CR36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00002371-199408000-00002","volume":"16","author":"MI Nishimura","year":"1994","unstructured":"Nishimura MI, Kawakami Y, Charmley P, O\u2019Neil B, Shilyansky J, Yannelli JR, Rosenberg SA, Hood L (1994) T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines. J Immunother Emphasis Tumor Immunol 16:85\u201394","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"99_CR37","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1073\/pnas.86.22.8941","volume":"86","author":"YW Choi","year":"1989","unstructured":"Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J (1989) Interaction of Staphylococcus aureus toxin \u201csuperantigens\u201d with human T cells. Proc Natl Acad Sci USA 86:8941\u20138945","journal-title":"Proc Natl Acad Sci USA"},{"key":"99_CR38","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1073\/pnas.90.9.4319","volume":"90","author":"C Pannetier","year":"1993","unstructured":"Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P (1993) The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 90:4319\u20134323","journal-title":"Proc Natl Acad Sci USA"},{"key":"99_CR39","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.4049\/jimmunol.158.3.1482","volume":"158","author":"D Serrano","year":"1997","unstructured":"Serrano D, Monteiro J, Allen SL, Kolitz J, Schulman P, Lichtman SM, Buchbinder A, Vinciguerra VP, Chiorazzi N, Gregersen PK (1997) Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol 158:1482\u20131489","journal-title":"J Immunol"},{"key":"99_CR40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10428190310001609898","volume":"45","author":"Y Tsutsumi","year":"2004","unstructured":"Tsutsumi Y, Tanaka J, Miura Y, Toubai T, Kato N, Fujisaw F, Toyoshima N, Ota S, Mori A, Yonezumi M, Chiba K, Kondo T, Hasino S, Kobayasi R, Masauji N, Kasai M, Asaka M, Imamura M (2004) Molecular analysis of T-cell repertoire in patients with graft-versus-host disease after allogeneic stem cell transplantation. Leuk Lymphoma 45:481\u2013488","journal-title":"Leuk Lymphoma"},{"key":"99_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/10428199809050927","volume":"30","author":"L Corput Van De","year":"1998","unstructured":"Van De Corput L, Falkenburg JH, Kluin-Nelemans JC (1998) T-cell dysfunction in hairy cell leukemia: an updated review. Leuk Lymphoma 30:31\u201339","journal-title":"Leuk Lymphoma"},{"key":"99_CR42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2004.08.011","volume":"16","author":"B Rocha","year":"2004","unstructured":"Rocha B, Tanchot C (2004) CD8 T cell memory. Semin Immunol 16:305\u2013314","journal-title":"Semin Immunol"},{"key":"99_CR43","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.4049\/jimmunol.153.9.4281","volume":"153","author":"F Farace","year":"1994","unstructured":"Farace F, Orlanducci F, Dietrich PY, Gaudin C, Angevin E, Courtier MH, Bayle C, Hercend T, Triebel F (1994) T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J Immunol 153:4281\u20134290","journal-title":"J Immunol"},{"key":"99_CR44","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood.V94.3.1063.415a17_1063_1069","volume":"94","author":"MR Rezvany","year":"1999","unstructured":"Rezvany MR, Jeddi-Tehrani M, Osterborg A, Kimby E, Wigzell H, Mellstedt H (1999) Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset. Blood 94:1063\u20131069","journal-title":"Blood"},{"key":"99_CR45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00002371-199809000-00004","volume":"21","author":"N Alatrakchi","year":"1998","unstructured":"Alatrakchi N, Farace F, Frau E, Carde P, Munck JN, Triebel F (1998) T-cell clonal expansion in patients with B-cell lymphoproliferative disorders. J Immunother 21:363\u2013370","journal-title":"J Immunother"},{"key":"99_CR46","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/sj.leu.2400714","volume":"11","author":"RD Brown","year":"1997","unstructured":"Brown RD, Yuen E, Nelson M, Gibson J, Joshua D (1997) The prognostic significance of T cell receptor beta gene rearrangements and idiotype-reactive T cells in multiple myeloma. Leukemia 11:1312\u20131317","journal-title":"Leukemia"},{"key":"99_CR47","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/79526","volume":"6","author":"JJ Molldrem","year":"2000","unstructured":"Molldrem JJ, LeePP, Wang C, Felio K, Kantarjian HM, Champlin RE, Davis MM (2000) Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 6:1018\u20131023","journal-title":"Nat Med"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-005-0099-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0099-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T16:35:52Z","timestamp":1683304552000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-005-0099-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,26]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["99"],"URL":"https:\/\/doi.org\/10.1007\/s00262-005-0099-1","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,26]]}}}